These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8440758)

  • 1. The effect of naproxen and interleukin-1 on proteoglycan catabolism and on neutral metalloproteinase activity in normal articular cartilage in vitro.
    Glazer PA; Rosenwasser MP; Ratcliffe A
    J Clin Pharmacol; 1993 Feb; 33(2):109-14. PubMed ID: 8440758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of naproxen on composition, proteoglycan metabolism, and matrix metalloproteinase activities in canine articular cartilage.
    Ratcliffe A; Azzo W; Saed-Nejad F; Lane N; Rosenwasser MP; Mow VC
    J Orthop Res; 1993 Mar; 11(2):163-71. PubMed ID: 8483029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of interleukin 1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate.
    Morris EA; Wilcon S; Treadwell BV
    Am J Vet Res; 1992 Nov; 53(11):1977-82. PubMed ID: 1466488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants.
    Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G
    Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
    Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by transforming growth factor-beta 1 and interleukin-1 beta of proteoglycan release and chondrodisaccharide composition in porcine articular cartilage.
    Zanni M; Tamburro A; Santone I; Rotilio D
    Semin Thromb Hemost; 1994; 20(2):159-67. PubMed ID: 7997887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation and inhibition of matrix metalloproteinase activities in articular cartilage.
    Glazer PA; Azzo W; Saed-Nejad F; Ratcliffe A
    Biochem Soc Trans; 1990 Oct; 18(5):1022-3. PubMed ID: 1964646
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
    Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent effects of interleukin 1 on proteoglycan synthesis and proteoglycan breakdown of bovine articular cartilage in vitro.
    Neidel J; Zeidler U
    Agents Actions; 1993 May; 39(1-2):82-90. PubMed ID: 8285145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proteoglycan metabolism, morphology and viability of articular cartilage treated with a synthetic matrix metalloproteinase inhibitor.
    Steinmeyer J; Daufeldt S; Kalbhen DA
    Res Exp Med (Berl); 1997; 197(2):63-79. PubMed ID: 9380952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of interleukin 1 on articular cartilage from young and aged horses and comparison with metabolism of osteoarthritic cartilage.
    Morris EA; Treadwell BV
    Am J Vet Res; 1994 Jan; 55(1):138-46. PubMed ID: 8141486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the hydroxamic acid derivate Ro 31-4724 on the metabolism and morphology of interleukin-1-treated cartilage explants.
    Steinmeyer J; Daufeldt S; Kalbhen DA
    Pharmacology; 1997 Aug; 55(2):95-108. PubMed ID: 9323309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.
    Andrews HJ; Plumpton TA; Harper GP; Cawston TE
    Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tiaprofenic acid and other NSAIDs on proteoglycan metabolism in articular cartilage explants.
    Muir H; Carney SL; Hall LG
    Drugs; 1988; 35 Suppl 1():15-23. PubMed ID: 3359943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro.
    Tyler JA
    Biochem J; 1985 Jan; 225(2):493-507. PubMed ID: 3919707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of interleukin-1 and insulin like growth factor-1 on the release of proteoglycan components and hyaluronan from pig articular cartilage in explant culture.
    Fosang AJ; Tyler JA; Hardingham TE
    Matrix; 1991 Feb; 11(1):17-24. PubMed ID: 2027327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
    Ganu V; Melton R; Wang W; Roberts D
    Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
    [No Abstract]   [Full Text] [Related]  

  • 18. IL-37 diminishes proteoglycan loss in human OA cartilage: donor-specific link between IL-37 and MMP-3.
    van Geffen EW; van Caam APM; Schreurs W; van de Loo FA; van Lent PLEM; Koenders MI; Thudium CS; Bay-Jensen AC; Blaney Davidson EN; van der Kraan PM
    Osteoarthritis Cartilage; 2019 Jan; 27(1):148-157. PubMed ID: 30201492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
    Armstrong S; Lees P
    Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo effects of naproxen on canine experimental osteoarthritic articular cartilage: composition, metalloproteinase activities and metabolism.
    Ratcliffe A; Rosenwasser MP; Mahmud F; Glazer PA; Saed-Nejad F; Lane N; Mow VC
    Agents Actions Suppl; 1993; 39():207-11. PubMed ID: 8456630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.